Sg3 Management, LLC Sangamo Therapeutics, Inc Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$1.66 - $3.67 $54,448 - $120,376	-32,800 Closed	0 $0
Q3 2022 May 15, 2023	BUY	$4.27 - $6.39 $140,056 - $209,592	32,800 New	32,800 $160,000
Q3 2022 Nov 14, 2022	BUY	$4.27 - $6.39 $140,056 - $209,592	32,800 New	32,800 $161,000
Q4 2021 Feb 15, 2022	SELL	$7.29 - $10.97 $72,900 - $109,700	-10,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$9.01 - $12.01 $67,575 - $90,075	7,500 Added 300.0%	10,000 $90,000
Q2 2021 Aug 16, 2021	BUY	$10.17 - $12.64 $25,425 - $31,600	2,500 New	2,500 $30,000

115

56.4M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $391M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.